Questionnaire for impulsive-compulsive disorders in Parkinson's Disease-Rating Scale

Movement Disorders

Volumn 27, Issue 2, 2012, Pages 242-247

  Weintraub, Daniel ^a,b   Mamikonyan, Eugenia ^a   Papay, Kimberly ^a   Shea, Judith A ^a,b   Xie, Sharon X ^c   Siderowf, Andrew ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Dopamine agonists; Impulse control disorder; Parkinson's disease

Indexed keywords

ADULT; ARTICLE; CHANGE RESPONSIVENESS; COMPULSIVE BUYING; COMPULSIVE MEDICATION USE; COMPULSIVE SEX; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISCRIMINANT VALIDITY; DOPAMINE DYSREGULATION SYNDROME; FEMALE; HOBBYISM PUNDING BEHAVIOR; HUMAN; IMPULSE CONTROL DISORDER; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PHAGOMANIA; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE FOR IMPULSIVE COMPULSIVE DISORDER IN PARKINSON DISEASE RATING SCALE; REFERENCE VALUE; SEMI STRUCTURED INTERVIEW; SENSITIVITY AND SPECIFICITY; STATISTICAL PARAMETERS; TEST RETEST RELIABILITY;

AGED; AREA UNDER CURVE; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; MIDDLE AGED; PARKINSON DISEASE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84856975120     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.24023     Document Type: Article

References (20)

1. Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients. Arch Neurol 2010; 67: 589-595.
2. Weintraub D, Siderowf AD, Potenza MN, et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 2006; 63: 969-973.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Text Revision. Washington, DC: American Psychiatric Association; 2000.
4. Grant JE, Steinberg MA, Kim SW, Rounsaville BJ, Potenza MN. Preliminary validity and reliability testing of a structured clinical interview for pathological gambling. Psychiatry Res 2004; 128: 79-88.
5. Voon V, Hassan K, Zurowski M, et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 2006; 67: 1254-1257.
6. McElroy SL, Keck PE, Pope HG, Smith JM, Strakowski SM. Compulsive buying: a report of 20 cases. J Clin Psychiatry 1994; 55: 242-248.
7. Giovannoni G, O'sullivan JD, Turner K, Manson AJ, Lees AJL. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 2000; 68: 423-428.
8. Christenson GA, Faber RJ, deZwaan M. Compulsive buying: descriptive characteristics and psychiatric comorbidity. J Clin Psychiatry 1994; 55: 5-11.
9. Lesieur HR, Blume SB. The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 1987; 144: 1184-1188.
10. Lejoyeux M, Tassain V, Solomon J, Adès J. Study of compulsive buying in depressed patients. J Clin Psychiatry 1997; 58: 169-173.
11. Evans AH, Katzenschlager R, Paviour D, et al. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord 2004; 19: 397-405.
12. Weintraub D, Stewart S, Shea JA, et al. Validation of the Questionnaire for Impulsive-Compulsive Behaviors in Parkinson's Disease (QUIP). Mov Disord 2009; 24: 1461-1467.
13. Fahn S, Elton RL; the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent developments in Parkinson's disease. Florham Park, NJ: Macmillan Health Care Information; 1987: 153-163.
14. Hobson DE, Lang AE, Martin WR, Razmy A, Rivest J, Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 2005; 287: 455-463.
15. Voon V, Fox SH. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 2007; 64: 1089-1096.
16. Bagby RM, Ryder AG, Schuller DR, Marshall MB. The Hamilton Depression Rating Scale: has the gold standard become a lead weight? Am J Psychiatry 2004; 161: 2163-2177.
17. Guy W. ECDEU Assessment Manual for Psychopharmacology-Revised, DHEW Publ No. (ADM) 76-338 ed. Rockville, MD: U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976.
18. Papay K, Mamikonyan E, Siderowf AD, et al. Patient versus informant reporting of ICD symptoms in Parkinson's disease using the QUIP: validity and variability. Parkinsonism Relat Disord 2011; 17: 153-155.
19. Ondo WG, Lai D. Predictors of impulsivity and reward seeking behavior with dopamine agonists. Parkinsonism Relat Disord 2008; 14: 28-32.
20. Holman AJ. Impulse control disorder behaviors associated with pramipexole used to treat fibromyalgia. J Gambl Stud 2009; 25: 425-431.